Orca Capital AG - 04 Sep 2025 SCHEDULE 13G/A Report for Purple Biotech Ltd. American Depositary Shares, each representing 200 Ordinary Shares (PPBT)

Filing Manager
Orca Capital AG
Reporting Manager
Orca Capital AG
Security
Purple Biotech Ltd. American Depositary Shares, each representing 200 Ordinary Shares
Symbol
PPBT
Shares outstanding
6,252,939 shares
Disclosed Ownership
306,394 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
09 Sep 2025, 16:24:55 UTC
Date of event
04 Sep 2025
SEC
View on sec.gov

Quoteable Key Fact

"Orca Capital AG disclosed 4.9% ownership in Purple Biotech Ltd. American Depositary Shares, each representing 200 Ordinary Shares (PPBT) on 04 Sep 2025."

Quick Takeaways

  • Orca Capital AG filed SCHEDULE 13G/A for Purple Biotech Ltd. American Depositary Shares, each representing 200 Ordinary Shares (PPBT).
  • Disclosed ownership: 4.9%.
  • Date of event: 04 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 09 Sep 2025, 16:24.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Orca Capital AG 4.9% 306,394 306,394 0 /s/ Thomas Konig Thomas Konig/Director